Biogen, Eisai's Leqembi wins EU authorization for some patients

European regulators on Tuesday authorized the use of Biogen and Eisai’s Alzheimer’s treatment Leqembi for some early-stage patients "under strict conditions." The decision from the European Commission makes Leqembi the "first treatment in Europe authorized ...

Apr 15, 2025 - 20:45
 0
Biogen, Eisai's Leqembi wins EU authorization for some patients
European regulators on Tuesday authorized the use of Biogen and Eisai’s Alzheimer’s treatment Leqembi for some early-stage patients "under strict conditions." The decision from the European Commission makes Leqembi the "first treatment in Europe authorized ...